Put Options Transactions Made in Q4 2023 in Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND) during Q4 2023. The information is specifically focused on institutions that hold put options of Ascendis Pharma A/S.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
PUT |
22.5KNew |
$1.94M - $2.87M
|
22.5K
$3.07M
|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
PUT |
1.3K+ 65.0% |
$112K - $166K
|
3.3K
$450K
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
PUT |
-600- 19.35% |
$51.7K - $76.4K
|
2.5K
$341K
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
SELL
|
PUT |
-5.3K- 72.6% |
$456K - $675K
|
2K
$273K
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-8K- 14.04% |
$689K - $1.02M
|
49K
$6.68M
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
PUT |
-9.2K- 64.34% |
$792K - $1.17M
|
5.1K
$696K
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
SELL
|
PUT |
-26.8K- 51.94% |
$2.31M - $3.41M
|
24.8K
$3.38M
|